|
Addressing racial bias in
treating sickle cell disease |
|
|
Sickle cell disease is just
one of the conditions that disproportionately impact underserved minority
communities. CVS Caremark® aims to help sickle cell
patients access appropriate medications and increase genetic trait testing.
Their plans include working with community partners to increase awareness
about HIV testing and prevention, and helping more people receive appropriate
medication for cardiovascular disease. |
|
|
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, January 12, 2022
Addressing racial bias in treating sickle cell disease
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment